New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareKisspeptin-10 vs SS-31 (Elamipretide)

Kisspeptin-10 vs SS-31 (Elamipretide)

Side-by-side comparison of key properties, dosing, and research.

Sexual Health & LibidoAnti-Aging & Longevity
Kisspeptin-10
Anti-Aging & Longevity
SS-31 (Elamipretide)
Summary
Kisspeptin-10 is the biologically active C-terminal decapeptide of kisspeptin, an endogenous regulator of the reproductive axis. It acts upstream of GnRH to potently stimulate LH and testosterone release, and plays a key role in sexual arousal and libido.
SS-31 (Elamipretide) is a synthetic mitochondria-targeting tetrapeptide that concentrates in the inner mitochondrial membrane and protects cardiolipin from oxidative damage. It is one of the most promising mitochondrial longevity compounds, studied in clinical trials for heart failure, renal disease, and age-associated mitochondrial dysfunction.
Half-Life
~4 minutes (rapidly degraded); longer-acting analogs like TAK-448 are in development
~2–5 hours
Admin Route
SubQ, IV
SubQ
Research
Typical Dose
50–500 mcg
5–10 mg
Frequency
Once daily to every other day
Daily to several times per week
Key Benefits
  • Potently stimulates LH and testosterone
  • Enhances sexual arousal and libido
  • Activates HPG axis — upstream of GnRH
  • May improve fertility in hypogonadotropic hypogonadism
  • Increases brain activation in sexual attraction circuits
  • May restore LH pulsatility in suppressed HPG axis
  • Restores mitochondrial function and ATP production
  • Protects inner mitochondrial membrane cardiolipin
  • Reduces mitochondrial reactive oxygen species (ROS)
  • Improves exercise capacity and reduces fatigue
  • Cardioprotective — studied in heart failure trials
  • Renoprotective — reduces ischemic kidney injury
  • Anti-aging via mitochondrial preservation
  • Potential in neurodegenerative disease prevention
Side Effects
  • Injection site reactions
  • Temporary nausea
  • Flushing
  • Elevated LH/testosterone (intended effect)
  • +1 more
  • Injection site irritation
  • Nausea (rare)
  • Generally well-tolerated in clinical trials
Stacks With